Bon Natural Life (BON) Competitors $0.06 0.00 (-1.53%) Closing price 04:00 PM EasternExtended Trading$0.06 -0.01 (-10.54%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock BON vs. NMTR, TRVN, EVFM, GRI, APVO, WINT, VIRX, ATXI, SYRS, and BIORShould you be buying Bon Natural Life stock or one of its competitors? The main competitors of Bon Natural Life include 9 Meters Biopharma (NMTR), Trevena (TRVN), Evofem Biosciences (EVFM), GRI Bio (GRI), Aptevo Therapeutics (APVO), Windtree Therapeutics (WINT), Viracta Therapeutics (VIRX), Avenue Therapeutics (ATXI), Syros Pharmaceuticals (SYRS), and Biora Therapeutics (BIOR). These companies are all part of the "pharmaceutical products" industry. Bon Natural Life vs. 9 Meters Biopharma Trevena Evofem Biosciences GRI Bio Aptevo Therapeutics Windtree Therapeutics Viracta Therapeutics Avenue Therapeutics Syros Pharmaceuticals Biora Therapeutics 9 Meters Biopharma (NASDAQ:NMTR) and Bon Natural Life (NYSE:BON) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, community ranking, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment. Does the MarketBeat Community favor NMTR or BON? 9 Meters Biopharma received 37 more outperform votes than Bon Natural Life when rated by MarketBeat users. CompanyUnderperformOutperform9 Meters BiopharmaOutperform Votes3771.15% Underperform Votes1528.85% Bon Natural LifeN/AN/A Does the media prefer NMTR or BON? In the previous week, Bon Natural Life had 2 more articles in the media than 9 Meters Biopharma. MarketBeat recorded 2 mentions for Bon Natural Life and 0 mentions for 9 Meters Biopharma. 9 Meters Biopharma's average media sentiment score of 0.00 equaled Bon Natural Life'saverage media sentiment score. Company Overall Sentiment 9 Meters Biopharma Neutral Bon Natural Life Neutral Which has better valuation and earnings, NMTR or BON? Bon Natural Life has higher revenue and earnings than 9 Meters Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio9 Meters BiopharmaN/AN/A-$43.77M-$3.46N/ABon Natural Life$23.84M0.01$400KN/AN/A Do insiders & institutionals hold more shares of NMTR or BON? 22.3% of 9 Meters Biopharma shares are held by institutional investors. Comparatively, 0.6% of Bon Natural Life shares are held by institutional investors. 2.4% of 9 Meters Biopharma shares are held by company insiders. Comparatively, 26.5% of Bon Natural Life shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, NMTR or BON? 9 Meters Biopharma has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Comparatively, Bon Natural Life has a beta of -0.51, indicating that its stock price is 151% less volatile than the S&P 500. Is NMTR or BON more profitable? Bon Natural Life's return on equity of 0.00% beat 9 Meters Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets 9 Meters BiopharmaN/A -584.97% -159.45% Bon Natural Life N/A N/A N/A SummaryBon Natural Life beats 9 Meters Biopharma on 6 of the 9 factors compared between the two stocks. Get Bon Natural Life News Delivered to You Automatically Sign up to receive the latest news and ratings for BON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BON vs. The Competition Export to ExcelMetricBon Natural LifeMedicinals & botanicals IndustryDiscretionary SectorNYSE ExchangeMarket Cap$269,000.00$1.16B$7.66B$19.22BDividend YieldN/AN/A3.39%4.00%P/E RatioN/A9.8016.7333.45Price / Sales0.0110.287.5129.18Price / Cash0.7810.4016.4217.52Price / Book0.001.504.554.55Net Income$400,000.00-$54.34M$261.05M$1.02B7 Day PerformanceN/A3.69%2.16%2.18%1 Month PerformanceN/A29.85%-1.29%-2.05%1 Year PerformanceN/A-33.58%-2.89%5.45% Bon Natural Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BONBon Natural LifeN/A$0.06-1.5%N/A-98.3%$269,000.00$23.84M0.00100NMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220TRVNTrevena0.7993 of 5 stars$1.20flat$5.00+318.4%-87.2%$1.03M$443,000.00-0.0340EVFMEvofem BiosciencesN/A$0.01-4.4%N/A-38.6%$975,000.00$11.39M-0.01120GRIGRI Bio2.2309 of 5 stars$1.78-2.2%$115.50+6,388.8%-97.9%$934,000.00N/A-0.151Upcoming EarningsPositive NewsAPVOAptevo Therapeutics2.5452 of 5 stars$0.61-9.3%$10,952.00+1,789,442.5%-100.0%$893,000.00$3.11M0.0050Upcoming EarningsGap DownWINTWindtree Therapeutics2.4224 of 5 stars$1.14-5.8%$350.00+30,601.8%-99.5%$854,000.00N/A-0.0730News CoveragePositive NewsGap DownVIRXViracta Therapeutics1.2569 of 5 stars$0.02-12.3%$4.06+20,949.2%-97.6%$767,000.00N/A-0.0220Gap DownATXIAvenue Therapeutics1.2149 of 5 stars$0.23-8.7%N/A-95.2%$724,000.00N/A0.014SYRSSyros Pharmaceuticals2.1298 of 5 stars$0.03-18.8%$3.33+12,720.5%-99.4%$698,000.00$386,000.00-0.01120Analyst ForecastNews CoverageGap DownBIORBiora TherapeuticsN/A$0.13flat$23.00+17,592.3%-97.8%$588,000.00$892,000.00-0.01120Gap Up Related Companies and Tools Related Companies 9 Meters Biopharma Competitors Trevena Competitors Evofem Biosciences Competitors GRI Bio Competitors Aptevo Therapeutics Competitors Windtree Therapeutics Competitors Viracta Therapeutics Competitors Avenue Therapeutics Competitors Syros Pharmaceuticals Competitors Biora Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BON) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bon Natural Life Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bon Natural Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
